- Home
- ELVN vs GDRX Comparison
ELVN vs GDRX Comparison
Compare ELVN & GDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELVN
- GDRX
- Stock Information
- Founded
- ELVN 2016
- GDRX 2011
- Country
- ELVN United States
- GDRX United States
- Employees
- ELVN N/A
- GDRX N/A
- Industry
- ELVN Biotechnology: Pharmaceutical Preparations
- GDRX Retail: Computer Software & Peripheral Equipment
- Sector
- ELVN Health Care
- GDRX Technology
- Exchange
- ELVN Nasdaq
- GDRX Nasdaq
- Market Cap
- ELVN 1.2B
- GDRX 1.2B
- IPO Year
- ELVN 2020
- GDRX 2020
- Fundamental
- Price
- ELVN $20.22
- GDRX $4.71
- Analyst Decision
- ELVN Strong Buy
- GDRX Buy
- Analyst Count
- ELVN 5
- GDRX 9
- Target Price
- ELVN $41.20
- GDRX $6.33
- AVG Volume (30 Days)
- ELVN 335.0K
- GDRX 5.5M
- Earning Date
- ELVN 08-13-2025
- GDRX 08-06-2025
- Dividend Yield
- ELVN N/A
- GDRX N/A
- EPS Growth
- ELVN N/A
- GDRX N/A
- EPS
- ELVN N/A
- GDRX 0.09
- Revenue
- ELVN N/A
- GDRX $799,874,000.00
- Revenue This Year
- ELVN N/A
- GDRX $5.54
- Revenue Next Year
- ELVN N/A
- GDRX $5.34
- P/E Ratio
- ELVN N/A
- GDRX $50.40
- Revenue Growth
- ELVN N/A
- GDRX 3.20
- 52 Week Low
- ELVN $13.30
- GDRX $3.31
- 52 Week High
- ELVN $30.03
- GDRX $8.80
- Technical
- Relative Strength Index (RSI)
- ELVN 49.43
- GDRX 53.45
- Support Level
- ELVN $19.30
- GDRX $4.28
- Resistance Level
- ELVN $20.28
- GDRX $5.41
- Average True Range (ATR)
- ELVN 1.19
- GDRX 0.30
- MACD
- ELVN 0.15
- GDRX 0.09
- Stochastic Oscillator
- ELVN 59.11
- GDRX 58.67
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.
About GDRX GoodRx Holdings Inc.
GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.